In order to establish a role for endogenous natriuretic peptides in limiting pathogenesis in IPF, and to confirm that the beneficial effects of combination therapy are dependent on natriuretic peptide bioactivity, we repeated representative studies in NPR-A KO animals. The gene discussed is NPR1; the disease is idiopathic pulmonary fibrosis.